Back
Thomson Reuters Vs. Neurogene Industry Stock Comparison
Sell
50
TRI.TO
Thomson Reuters
Last Price:
235.81
Seasonality Move:
3.36%
Sell
13
NGNE
Neurogene
Last Price:
39.61
Seasonality Move:
50.43%
Sell
50
Thomson Reuters (TRI.TO)
is a Sell
Is Thomson Reuters a Buy, Sell or Hold?
- The current Thomson Reuters [TRI.TO] share price is $236.50. The Score for TRI.TO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- TRI.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $40.00. The Score for NGNE is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
TRI.TO Stock Price Chart
What is Thomson Reuters's stock price today?
-
The Thomson Reuters share price today is $236.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRI.TO is experiencing selling pressure, which indicates risk of future bearish movement.
TRI.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.28 | Buy |
| Relative Strength Index (14 RSI): | 59.24 | Buy |
| Chaikin Money Flow: | 204399 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.99 | Buy |
| Relative Strength Index (14 RSI): | 39.4 | Sell |
| Chaikin Money Flow: | -718137 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
TRI.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 233.5 | Buy |
| 20-day SMA: | 232.02 | Buy |
| 50-day SMA: | 230.97 | Buy |
| 200-day SMA: | 222.91 | Buy |
| 8-day EMA: | 233.95 | Buy |
| 20-day EMA: | 232.38 | Buy |
| 50-day EMA: | 230.7 | Buy |
| 200-day EMA: | 220.28 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.21 | Sell |
| 20-day SMA: | 53.69 | Sell |
| 50-day SMA: | 46.52 | Sell |
| 200-day SMA: | 38.9 | Buy |
| 8-day EMA: | 58.17 | Sell |
| 20-day EMA: | 54.62 | Sell |
| 50-day EMA: | 48.72 | Sell |
| 200-day EMA: | 38.46 | Buy |
Thomson Reuters Earnings Growth & TRI.TO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.44 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Thomson Reuters Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||